TY - JOUR
T1 - Using artificial intelligence methods for systematic review in health sciences
T2 - A systematic review
AU - Blaizot, Aymeric
AU - Veettil, Sajesh
AU - Saidoung, Pantakarn
AU - Moreno-Garcia, Carlos
AU - Wiratunga, Nirmalie
AU - Aceves Martins, Magaly
AU - Ming Lai, Nai
AU - Chaiyakunapruk, Nathorn
N1 - The authors thank Mr. Josh Higashi for aiding in the post-hoc full-text screening.
PY - 2022/5/9
Y1 - 2022/5/9
N2 - The exponential increase in published articles makes a thorough and expedient review of literature increasingly challenging. This review delineated automated tools and platforms that employ artificial intelligence (AI) approaches and evaluated the reported benefits and challenges in using such methods. A search was conducted in 4 databases (Medline, Embase, CDSR, and Epistemonikos) up to April 2021 for systematic reviews and other related reviews implementing AI methods. To be included, the review must use any form of AI method, including machine learning, deep learning, neural network, or any other applications used to enable the full or semi-autonomous performance of one or more stages in the development of evidence synthesis. Twelve reviews were included, using nine different tools to implement 15 different AI methods. Eleven methods were used in the screening stages of the review (73%). The rest were divided: two in data extraction (13%) and two in risk of bias assessment (13%). The ambiguous benefits of the data extractions, combined with the reported advantages from 10 reviews, indicating that AI platforms have taken hold with varying success in evidence synthesis. However, the results are qualified by the reliance on the self-reporting of the review authors. Extensive human validation still appears required at this stage in implementing AI methods, though further evaluation is required to define the overall contribution of such platforms in enhancing efficiency and quality in evidence synthesis.
AB - The exponential increase in published articles makes a thorough and expedient review of literature increasingly challenging. This review delineated automated tools and platforms that employ artificial intelligence (AI) approaches and evaluated the reported benefits and challenges in using such methods. A search was conducted in 4 databases (Medline, Embase, CDSR, and Epistemonikos) up to April 2021 for systematic reviews and other related reviews implementing AI methods. To be included, the review must use any form of AI method, including machine learning, deep learning, neural network, or any other applications used to enable the full or semi-autonomous performance of one or more stages in the development of evidence synthesis. Twelve reviews were included, using nine different tools to implement 15 different AI methods. Eleven methods were used in the screening stages of the review (73%). The rest were divided: two in data extraction (13%) and two in risk of bias assessment (13%). The ambiguous benefits of the data extractions, combined with the reported advantages from 10 reviews, indicating that AI platforms have taken hold with varying success in evidence synthesis. However, the results are qualified by the reliance on the self-reporting of the review authors. Extensive human validation still appears required at this stage in implementing AI methods, though further evaluation is required to define the overall contribution of such platforms in enhancing efficiency and quality in evidence synthesis.
KW - artificial intelligence
KW - evidence synthesis
KW - machine learning
KW - systematic reviews
UR - http://www.scopus.com/inward/record.url?scp=85125397472&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/78dddfb5-ee39-3233-a4a2-1439f12c1e74/
U2 - 10.1002/jrsm.1553
DO - 10.1002/jrsm.1553
M3 - Review article
VL - 13
SP - 353
EP - 362
JO - Research Synthesis Methods
JF - Research Synthesis Methods
SN - 1759-2887
IS - 3
ER -